Research and Clinical Trials
Search Cancer Clinical Trials
Clinical Trials
New Search
| Title | Phase 2 Study of Thermodox as Adjuvant Therapy With Radiofrequency Ablation (RFA) in Treatment of Colorectal Liver Metastases (CRLM) (ABLATE) |
|---|---|
| Disease/Condition | Colon Cancer |
| Description | The purpose of this study is to determine the safety and efficacy of Thermodox, a thermally sensitive liposomal doxorubicin, in combination with RFA, in the treatment of recurrent or refractory colorectal liver metastases compared to RFA monotherapy. |
| Eligibility Criteria | To be eligible for this study, patients must meet several criteria, including but not limited to the following: * Patient must be 18 Years and older * Patient must have a pathologic diagnosis of colorectal cancer * Patient must be willing to return to the study site for study visits. |
| Principal Investigator | Steven K. Libutti, MD |
| Contact Email | slibutti@montefiore.org |
| Post Date | 11/01/2011 |
| Protocol Number | 11-06-111/West |
| Status | Recruiting |
| Current Trial Type | Interventional |
